Keeping Track: First RMAT Approval On The Horizon; Big Weeks For Merck, Lilly And Celgene

The latest drug development news and highlights from our US FDA Performance Tracker.

Keeping Track Feature image

As the US Food and Drug Administration and industry cannonballed into June with an explosion of drug development announcements, it was impossible to keep the news brief. So we'll skip the preamble this week and bring you directly to the meat of the action.

It looks like 2019 will be the year the FDA approves the first product with a regenerative medicine advanced therapy...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Product Reviews

More from Pink Sheet